The event featured engaging keynote presentations, interactive panel discussions, and hands-on learning opportunities that ...

One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators.

Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) is projected to release its earnings data after the market closes on Tuesday, February 18th. Analysts expect Tactile Systems Technology to ...

Fintel reports that on February 19, 2025, B. Riley Securities downgraded their outlook for Tactile Systems Technology ...

Interim follow-up data indicate sustained improvements across all venous specific quality-of-life (QoL) indicators. PMA application for the VenoValve submitted in November 2024, with an FDA decision ...

MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical”; the "Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...

On the heels of Nimbl’s launch for patients with upper extremity swelling, we are pleased to now expand access to the 16 million Americans with chronic swelling in the lower extremities,” said Sheri ...

Symptoms of severe CVI include leg swelling, pain, edema, and in the most severe ... being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also ...